Abbott Laboratories (TSX:ABT)
20.10
-0.27 (-1.33%)
At close: Mar 3, 2026
Abbott Laboratories Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8,522 | 7,616 | 6,896 | 9,882 | 9,799 |
Short-Term Investments | 417 | 351 | 383 | 288 | 450 |
Cash & Short-Term Investments | 8,939 | 7,967 | 7,279 | 10,170 | 10,249 |
Cash Growth | 12.20% | 9.45% | -28.43% | -0.77% | 43.38% |
Accounts Receivable | 7,929 | 6,925 | 6,565 | 6,218 | 6,487 |
Other Receivables | 2,640 | 2,570 | 2,256 | 2,663 | 2,346 |
Total Trade Receivables | 10,569 | 9,495 | 8,821 | 8,881 | 8,833 |
Inventory | 6,488 | 6,194 | 6,570 | 6,173 | 5,157 |
Other Current Assets | 2,640 | 2,570 | 2,256 | 2,663 | 2,346 |
Total Current Assets | 25,996 | 23,656 | 22,670 | 25,224 | 24,239 |
Net Property, Plant & Equipment | 37,038 | 33,398 | 32,087 | 29,374 | 28,323 |
Other Intangible Assets | 5,526 | 6,647 | 8,815 | 10,454 | 12,739 |
Goodwill | 24,035 | 23,108 | 23,679 | 22,799 | 23,231 |
Long-Term Investments | 918 | 886 | 799 | 766 | 816 |
Other Long-Term Assets | 18,422 | 16,459 | 7,097 | 6,033 | 5,212 |
Total Assets | 86,713 | 81,414 | 73,214 | 74,438 | 75,196 |
Accounts Payable | 4,240 | 4,195 | 4,295 | 4,607 | 4,408 |
Accrued Expenses | 7,557 | 6,844 | 7,019 | 7,401 | 6,806 |
Current Portion of Long-Term Debt | 3,033 | 1,500 | 1,080 | 2,251 | 754 |
Other Current Liabilities | 1,666 | 1,618 | 1,447 | 1,230 | 1,137 |
Total Current Liabilities | 16,496 | 14,157 | 13,841 | 15,489 | 13,105 |
Long-Term Debt | 9,896 | 12,625 | 13,599 | 14,522 | 17,296 |
Other Long-Term Liabilities | 7,550 | 6,731 | 6,947 | 7,522 | 8,771 |
Total Long-Term Liabilities | 17,446 | 19,356 | 20,546 | 22,044 | 26,067 |
Total Liabilities | 33,942 | 33,513 | 34,387 | 37,533 | 39,172 |
Common Stock | 25,527 | 25,153 | 24,869 | 24,709 | 24,470 |
Treasury Stock | -17,177 | -16,844 | -15,981 | -15,229 | -11,822 |
Accumulated Other Comprehensive Income | -6,001 | -7,906 | -7,839 | -8,051 | -8,374 |
Retained Earnings | 49,781 | 47,261 | 37,554 | 35,257 | 31,528 |
Total Common Shareholders' Equity | 52,130 | 47,664 | 38,603 | 36,686 | 35,802 |
Minority Interest | 641 | 237 | 224 | 219 | 222 |
Shareholders' Equity | 52,771 | 47,901 | 38,827 | 36,905 | 36,024 |
Total Liabilities & Equity | 86,713 | 81,414 | 73,214 | 74,438 | 75,196 |
Total Debt | 12,929 | 14,125 | 14,679 | 16,773 | 18,050 |
Net Cash (Debt) | -3,990 | -6,158 | -7,400 | -6,603 | -7,801 |
Net Cash Per Share | -2.28 | -3.52 | -4.23 | -3.74 | -4.36 |
Book Value | 52,130 | 47,664 | 38,603 | 36,686 | 35,802 |
Book Value Per Share | 29.82 | 27.27 | 22.07 | 20.80 | 20.01 |
Tangible Book Value | 22,569 | 17,909 | 6,109 | 3,433 | -168 |
Tangible Book Value Per Share | 12.91 | 10.25 | 3.49 | 1.95 | -0.09 |
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.